Celularity (CELU) Capital Expenditures (2020 - 2024)
Celularity's Capital Expenditures came in at $1.43 million for Q4 2024, up 146.6% from $580,000 a year earlier.
Powered by 
Analysis
Celularity (CELU) Capital Expenditures (2020 - 2024) Analysis & Trends
For FY2024, Celularity's Capital Expenditures was $1.5 million, up 43.1% from FY2023.
- Capital Expenditures carries a four-year compound annual growth rate of -51.8% (FY2020 to FY2024).
- Going back by year, Capital Expenditures was $1.05 million in FY2023 (-80.0%), $5.24 million in FY2022 (-15.6%), $6.2 million in FY2021 (-77.7%) and $27.83 million in FY2020.
- The Q4 2024 figure represents the highest quarterly Capital Expenditures since Q3 2022.
- Year-over-year, Capital Expenditures increased in 1 of the last seven quarters, with an average decline of 32.7%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2024 (growth of 146.6%), and the weakest in Q2 2023 (a decline of 97.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.43 Mn |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | 580,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 209,000.00 |
| Dec 31, 2022 | 779,000.00 |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 1.45 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 1.48 Mn |
| Dec 31, 2020 | 9.37 Mn |
API Access
Celularity Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();